Skip to content

An analysis of factors influencing short-term and long-term prognosis in patients with acute-on-chronic liver failure

An analysis of factors influencing short-term and long-term prognosis in patients with acute-on-chronic liver failure

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400089149
Enrollment
Unknown
Registered
2024-09-02
Start date
2024-10-01
Completion date
Unknown
Last updated
2024-09-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute-on-chronic liver failure

Interventions

Acute-on-chronic liver failure patients group :none

Sponsors

West China Hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 90 Years

Inclusion criteria

Inclusion criteria: On the basis of chronic liver disease, acute or subacute liver decompensation in the short term clinical syndrome,characterized by: 1. Extreme fatigue, there is a clear gastrointestinal symptoms; 2. Jaundice rapidly deepen, serum total bilirubin 10 times greater than the upper limit of normal or daily rise >=17.1 u mol/L; 3. With bleeding tendency, prothrombin activity (PTA)=1.5], without other causes; 4. Decompensated ascites; 5. With or without hepatic encephalopathy; 6. There are 3 months and 1 year follow-up ending.

Exclusion criteria

Exclusion criteria: 1. Combined with liver cancer and other malignant tumors; 2. Pregnant and lactating women; 3. Participants with poor adherence as well as patients who give up treatment; 4. The clinical data and test data were missing.

Design outcomes

Primary

MeasureTime frame
Serum biochemical index, including ALT, AST, ALP, GGT, serum sodium, triglycerides, cholesterol, total protein, albumin, prealbumin, DBIL, IBIL, creatinine, blood uric acid, and lactic dehydrogenase;Blood ammonia;Routine analysis of blood, including hemoglobin, red blood cell count, platelet count, neutrophil count, lymphocyte count, monocyte count and so on;Coagulation routine, including INR, PTA;AFP;Survival situation;

Secondary

MeasureTime frame
HBV DNA load;Clinical comorbidities and treatment status;

Countries

China

Contacts

Public ContactXuezhong Lei

West China Hospital, Sichuan University

chenenqiang1983@hotmail.com+86 189 8060 6517

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026